Company Filing History:
Years Active: 2015
Title: Eli Karin Dale: Innovator in Pharmaceutical Purification Processes
Introduction
Eli Karin Dale, an accomplished inventor based in Oslo, Norway, has made significant contributions to the field of pharmaceuticals through his innovative methods for purifying critical compounds. With a total of two patents to his name, Dale's work aims to enhance the effectiveness and safety of pharmaceutical products.
Latest Patents
Dale's latest patents showcase his expertise in the purification of lipopeptides. The first patent, titled "Process for Purifying Lipopeptides," specifically details an advanced method for purifying daptomycin, a crucial antibiotic. His second patent, "Method for Purification of Micafungin," outlines a novel approach where a micafungin starting material containing a first micafungin salt is adsorbed to a solid support. Dale’s method further involves washing the adsorbed micafungin with an aqueous solution containing a dissolved second salt, allowing for the effective elution of the second micafungin salt using a water-miscible organic solvent.
Career Highlights
Eli Karin Dale works at Xellia Pharmaceuticals ApS, a leading company in providing high-quality pharmaceuticals. His role in the organization emphasizes the importance of innovation in therapeutic solutions, particularly in enhancing the efficacy of existing drugs through improved purification processes.
Collaborations
Throughout his career, Eli has collaborated with esteemed colleagues such as Martin Mansson and Sissel Hauge. These partnerships underline the collaborative spirit of innovation within the pharmaceutical industry, where teamwork is essential for overcoming challenges and driving advancements.
Conclusion
Eli Karin Dale exemplifies the essence of innovation in pharmaceuticals with his contributions to the purification of vital compounds. His patents not only improve the quality of important medications like daptomycin and micafungin but also serve as a testament to the impact that dedicated inventors can have on public health and the pharmaceutical industry. Through his work at Xellia Pharmaceuticals, Dale continues to push the boundaries of what is possible in drug development and purification methods.